Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope

被引:36
作者
Otahal, P [1 ]
Hutchinson, SC [1 ]
Mylin, LM [1 ]
Tevethia, MJ [1 ]
Tevethia, SS [1 ]
Schell, TD [1 ]
机构
[1] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA
关键词
D O I
10.4049/jimmunol.175.2.700
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T lymphocytes (T-CD8) responding to subdominant epitopes provide alternate targets for the immunotherapy of cancer, particularly when self-tolerance limits the response to immunodominant epitopes. However, the mechanisms that promote T-CD8 subdominance to tumor Ags remain obscure. We investigated the basis for the lack of priming against (B6) mice with SV40 large tumor Ag (T Ag)-transformed cells. Immunization of B6 mice with wild-type T Ag-transformed cells primes T-CD8 specific for three immunodominant T Ag epitopes (epitopes I, II/III, and IV) but fails to induce T-CD8 specific for the subdominant T Ag epitope V. Using adoptively transferred T-CD8 from epitope V-specific TCR transgenic mice and immunization with T Ag-transformed cells, we demonstrate that the subdominant epitope V is weakly cross-presented relative to inummodominant epitopes derived from the same protein Ag. Priming of naive epitope V-specific TCR transgenic T-CD8 in B6 mice required cross-presentation by host APC. However, robust expansion of these T-CD8 required additional direct presentation of the subdominant epitope by T Ag-transformed cells and was only significant following immunization with T Ag-expressing cells lacking the inummodominant epitopes. These results indicate that limited cross-presentation coupled with competition by inummodominant epitope-specific T-CD8 contributes to the subdominant nature of a tumor-specific epitope. This finding has implications for vaccination strategies targeting T-CD8 responses to cancer.
引用
收藏
页码:700 / 712
页数:13
相关论文
共 83 条
[1]   The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens [J].
Belz, GT ;
Behrens, GMN ;
Smith, CM ;
Miller, JFAP ;
Jones, C ;
Lejon, K ;
Fathman, CG ;
Mueller, SN ;
Shortman, K ;
Carbone, FR ;
Heath, WR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (08) :1099-1104
[2]   CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) :1283-1288
[3]   T cell affinity maturation by selective expansion during infection [J].
Busch, DH ;
Pamer, EG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) :701-709
[4]  
Butz EA, 1998, J IMMUNOL, V160, P2139
[5]  
CAMPBELL AE, 1983, J IMMUNOL, V130, P490
[6]   SIMIAN-VIRUS-40 LARGE T-ANTIGEN CONTAINS 2 INDEPENDENT ACTIVITIES THAT COOPERATE WITH A RAS ONCOGENE TO TRANSFORM RAT EMBRYO FIBROBLASTS [J].
CAVENDER, JF ;
CONN, A ;
EPLER, M ;
LACKO, H ;
TEVETHIA, MJ .
JOURNAL OF VIROLOGY, 1995, 69 (02) :923-934
[7]   Differential transcriptional regulation of individual TCR Vβ segments before gene rearrangement [J].
Chen, F ;
Rowen, L ;
Hood, L ;
Rothenberg, EV .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1771-1780
[8]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[9]   Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon [J].
Chen, WS ;
Masterman, KA ;
Basta, S ;
Haeryfar, SMM ;
Dimopoulos, N ;
Knowles, B ;
Bennink, JR ;
Yewdell, JW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (01) :194-199
[10]   Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses [J].
Chen, WS ;
Antón, LC ;
Bennink, JR ;
Yewdell, JW .
IMMUNITY, 2000, 12 (01) :83-93